Research
Energy balance
There is a need for a dedicated trial to examine the benefits of semaglutide in type 1 diabetes.
Further research is warranted to validate the effects of semaglutide in type 1 diabetes.
StrongSupportsmedium confidence
This case supports the need for a dedicated trial examining potential benefits of semaglutide in T1DM.
Why this rating
The findings are based on a case study with clear outcomes.
Source
Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes
Lisa M. Raven et al. · JCEM Case Reports · 2022
DOI 10.1210/jcemcr/luac017
case_studyCited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →